AzTrials
AzTrials

Hemodialysis PatientsNCT05867446

The Effect of Education Given to Hemodialysis Patients With Pecha Kuka Method on Attitude Towards Diet Therapy and Compliance With Fluid Restriction

A study testing pecha kucha in people with Hemodialysis Patients, run by Ataturk University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Hemodialysis complex treatment regimen includes fluid and diet management. In this context, it is recommended that patients choose foods with low sodium, potassium and phosphorus content, maintain adequate protein intake, and regulate their daily fluid intake not exceeding 1-2 liters. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Hemodialysis Patients
What is being tested?
pecha kucha
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2025to 1 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • The patient does not have any impairment (such as vision, speech and hearing) that prevents him from communicating.
  • Accepting the research
  • Being receiving hemodialysis treatment
  • Ability to communicate adequately
  • Absence of psychiatric problems

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Gülcan B Turan

    Elâzığ, Merkez, 23000

Other trials in Turkey (Türkiye)

About this study

Hemodialysis complex treatment regimen includes fluid and diet management. In this context, it is recommended that patients choose foods with low sodium, potassium and phosphorus content, maintain adequate protein intake, and regulate their daily fluid intake not exceeding 1-2 liters. In maintaining the health of hemodialysis patients; It is very important that they comply with the treatment program, diet and fluid restrictions. As the life expectancy increases, the time spent with chronic disease also increases, and both the patient himself and his relatives living in the same house are faced with this chronic disease and accompanying stress factors for a longer period of time, making it difficult for them to adapt to the progression of the disease.

Pecha Kucha (PK), meaning "chat voice" or "chat" in Japanese, refers to a well-crafted, fast and concise presentation format. In a PK presentation, each presenter is only allowed to show 20 PowerPoint slides for 20 seconds each on a timer. When the literature was examined, no study was found that evaluated the effect of the education given to hemodialysis patients with the Pecha Kuka method on the attitude towards diet therapy and compliance with fluid restriction. In addition, it is thought that this short and concise education method will contribute to a better understanding of the attitudes of patients receiving hemodialysis treatment towards diet therapy and their compliance with fluid restriction, thus providing important data for future studies.

Read the detailed description

Diet is one of the most important elements of HD treatment. Kidney disease can be slowed down with diet. There are important issues in the diet of individuals receiving HD treatment. Adequate energy consumption comes first. Individuals receiving HD treatment must meet the energy requirements needed to maintain their health, as well as perform their metabolic functions. Adequate protein intake is one of the important issues in the diet in patients receiving HD treatment. Compliance with disease treatment; it is briefly defined as "individual compliance with medical treatment and health recommendations". During the period of hemodialysis treatment, one of the areas where individuals have difficulty in adapting is diet and fluid restriction. Because the disease and HD treatment directly affect the eating habits and preferences of individuals. As with all chronic diseases, it is very important for individuals who continue HD treatment to comply with the drug treatment program, diet and fluid restrictions in order to maintain their health. refers to a fast and concise presentation format. It was created in 2003 by architects Astrid Klein and Mark Dytham, who hoped to give young designers the opportunity to present their work in a short, fast-paced setting. In a PK presentation, each presenter is only allowed to show 20 PowerPoint slides for 20 seconds each on a timer. In other words, the presenter has only 20 seconds to discuss each slide before the next slide appears, and the presentation time is limited to 6 minutes and 40 seconds. Ideas are explained visually with pictures and graphics, and there is little text on the slides.

Being tested
pecha kucha
Keywords
diet, liquid, patients, nurse

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • pecha kuchaBehavioural

    pecha kucha training

Study groups in NCT05867446
Study groupRoleWhat they receive
Experimental:Experimentalpecha kucha will be practiced
Receives: Behavioral: pecha kucha
controlNo interventionRoutine maintenance will be applied.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Attitude Scale Towards Dietary Treatment of Hemodialysis Patients

    "Attitude Scale Towards Dietary Treatment of Hemodialysis Patients" is a 16-item scale developed by Onbe and Kanda in 2018 to determine the attitudes of patients towards diet therapy. It is a 4 likert scale.

    Each item represents 1-Strongly agree, 2-Agree, 3-Disagree, 4-Strongly Disagree. This scale consists of 3 sub-dimensions.

    1. Sub size; "Behavioral tendency affected by cognition" includes 7 items (1,2,3,4,5,6,7).
    2. Sub-dimension; "Behavioral tendency affected by food culture" includes 6 (8,9,10,11,12,13) items.
    3. Sub-dimension; "Negative effect that changes diet" includes 3 items (14,15,16). The last three items in the scale are reversed.

    Higher scores obtained from the scale indicate that attitudes are better. Effect on Retention and Fluid Restriction Compliance

    Measured: 1 hours later

  2. Dialysis Diet and Fluid Restriction Compliance Scale

    It was developed by Vlaminck et al. (2001), and its Turkish validity and reliability study was performed by Kara (2009) in hemodialysis patients. WHO is a four-item self-report tool used to evaluate non-adherence to diet and fluid intake restriction in hemodialysis patients. Two items in the scale deal with diet (items 1 and 2), and the other two deal with fluid restriction (items 3 and 4) in terms of frequency and degree. The frequency of non-compliance with diet and fluid restriction is based on the behaviors of the patients in the previous 14 days. The degree of non-compliance with diet and fluid restriction has a Likert-type structure scored between 0-4 (No non-compliance = 0, Mild = 1, Moderate = 2, Severe = 3, Very severe =4) The Cronbach alpha coefficient of the scale was reported as 0.70.

    Measured: 1 hours later

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2023
  2. Study start1 Jan 2025
  3. Primary completion1 Jun 2025
  4. Study completion1 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
pecha kucha training
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05867446
Sponsor's protocol ID
2023/ 04- 12
Status last verified
Feb 2026
First submitted
12 Apr 2023
Last updated
24 Feb 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing pecha kucha in people with Hemodialysis Patients, run by Ataturk University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Attitude Scale Towards Dietary Treatment of Hemodialysis Patients (time frame: 1 hours later). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in